Tulane University Study Links Nighttime Light Exposure to Cardiovascular Disease Risk
Exposure to artificial light during sleep—even at levels as low as 3 lux, roughly the brightness of moonlight—is associated with a higher risk of cardiovascular disease, according to a new study from Tulane University. Researchers found that nighttime light exposure correlates with increased risks of heart failure, atrial fibrillation, heart attack, stroke, and cardiovascular death.
The findings build on broader research examining how ambient light at night impacts human health. A separate study involving 466 adults tracked via Massachusetts General Hospital scans found that higher levels of artificial light at night increased the likelihood of a heart attack by 35% over five years and 22% over a 10-year period.
How Circadian Rhythms and Melatonin Respond to Bedroom Lighting
Sleep is partially controlled by the circadian rhythm, which acts as the brain’s internal 24-hour clock regulating sleep and wakefulness, according to Chelsie Rohrscheib, Ph.D., a sleep expert and neuroscientist based in Michigan. Light entering the eyes signals the brain to suppress melatonin production, a hormone that manages the timing of sleep.
“As melatonin levels rise in the evening, they help prepare the brain and body for sleep,” Rohrscheib told Fox News Digital. “Light pollution from various sources in our bedroom can trick the brain into producing less melatonin, which can negatively impact sleep quality.”
Consistent light exposure chronically reduces overall sleep quality, interrupting biological processes such as hormone release, immune system function, and metabolic regulation. Rohrscheib noted that a 2022 Northwestern Medicine study demonstrated how just one night of sleeping with moderate light exposure at 100 lux disrupted glucose regulation while increasing heart rate and sympathetic nervous system activity.
Vulnerable Populations and the Impact of Blue Wavelengths
Certain groups face heightened sensitivity to nighttime light exposure. Alex Dimitriu, M.D., a double board-certified sleep medicine doctor and founder of Menlo Park Psychiatry & Sleep Medicine, told Fox News Digital that shift workers, children, older adults, and individuals with insomnia or mood disorders are especially vulnerable to the disruption of sleep depth.
Different types of light carry varying levels of disruption. Dimitriu explained that blue wavelength light from televisions and mobile phones is the most disruptive because human retinas are most sensitive to it, leading to maximal melatonin suppression. Conversely, dim, warm, red-toned night lights cause far less circadian impact, mirroring natural sunset colors.
Ashley Curtis, PhD, a sleep researcher and assistant professor at the University of South Florida College of Nursing, agreed that warmer, dimmer light with longer wavelengths does not impact melatonin production to the same severe degree as brighter light, allowing the body time to recover.
Pro Tip: Cultivating a Healthy Sleep Environment
Experts recommend several practical changes to optimize your bedroom without requiring pitch-black conditions:
- Turn off harsh overhead lights one to two hours before bed.
- Place night lights close to the floor.
- Use bulbs that are dimmer and emit warmer light, such as orange, amber, or red.
- Discontinue screen use at least one hour before bedtime.
- Layer window treatments to soften bright street lighting, or consider a face mask.
Frequently Asked Questions
How much light exposure during sleep is considered harmful?
Research from Tulane University links exposure to more than 3 lux of light—roughly equivalent to moonlight—to increased cardiovascular risks, including heart attack, stroke, and heart failure.
Why is blue light more disruptive to sleep than other colors?
According to Alex Dimitriu, M.D., human retinas are most sensitive to blue wavelength light from screens like phones and TVs, which maximally suppresses the production of the sleep hormone melatonin.
Do older adults react to nighttime light the same way younger adults do?
Ashley Curtis, PhD, notes that older adults often become less sensitive to light, meaning short-wavelength light has a weaker direct effect on suppressing melatonin compared to younger demographics, though older populations already experience a higher baseline prevalence of sleep disruption.
To learn more about maintaining healthy sleep habits and protecting your long-term cardiovascular health, explore our related health resources or subscribe to our newsletter for weekly updates.
Keep reading
- Cholesterol Supplement Lowers Lipids in Healthy Adults: RCT
- Medicare Open Enrollment: Why Seniors May Need a New Plan This Year
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)